STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $273,000 | -54.4% | 56,322 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $599,000 | +5.8% | 56,322 | +3.5% | 0.00% | 0.0% |
| Q3 2019 | $566,000 | -29.6% | 54,398 | +3.7% | 0.00% | -50.0% |
| Q2 2019 | $804,000 | +27.2% | 52,453 | +6.6% | 0.00% | +100.0% |
| Q1 2019 | $632,000 | +79.0% | 49,184 | +32.4% | 0.00% | 0.0% |
| Q4 2018 | $353,000 | -15.8% | 37,138 | +47.2% | 0.00% | 0.0% |
| Q3 2018 | $419,000 | -32.7% | 25,227 | -35.0% | 0.00% | 0.0% |
| Q2 2018 | $623,000 | +56.1% | 38,788 | +48.9% | 0.00% | 0.0% |
| Q1 2018 | $399,000 | +10.5% | 26,056 | +12.6% | 0.00% | 0.0% |
| Q4 2017 | $361,000 | +17.6% | 23,141 | -16.3% | 0.00% | 0.0% |
| Q3 2017 | $307,000 | +21.8% | 27,648 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $252,000 | +27.9% | 27,358 | +18.5% | 0.00% | – |
| Q1 2017 | $197,000 | -4.4% | 23,078 | +20.0% | 0.00% | -100.0% |
| Q4 2016 | $206,000 | -24.3% | 19,231 | -23.4% | 0.00% | 0.0% |
| Q3 2016 | $272,000 | +52.8% | 25,107 | -4.4% | 0.00% | 0.0% |
| Q2 2016 | $178,000 | +76.2% | 26,260 | +20.9% | 0.00% | – |
| Q1 2016 | $101,000 | -18.5% | 21,722 | +10.8% | 0.00% | – |
| Q4 2015 | $124,000 | -27.1% | 19,597 | +2.1% | 0.00% | -100.0% |
| Q3 2015 | $170,000 | -20.6% | 19,202 | +5.4% | 0.00% | 0.0% |
| Q2 2015 | $214,000 | +8.6% | 18,218 | +34.0% | 0.00% | 0.0% |
| Q1 2015 | $197,000 | -48.0% | 13,598 | +62.7% | 0.00% | 0.0% |
| Q3 2013 | $379,000 | – | 8,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|